GlaxoSmithKline (GSK) has declined to comment on a report a US private equity firm is readying a bid for its Lucozade and Ribena brands.
UK: GlaxoSmithKline silent on talk of private equity swoop for Lucozade, Ribena
GlaxoSmithKline (GSK) has declined to comment on a report a US private equity firm is readying a bid for its Lucozade and Ribena brands.